Hepatitis C: Short Term Drug Costs Versus Long Term Care Costs

Author(s):

Davy James, Managing Editor

Marc O'Connor, Chief Operating Officer of Curant Health, discusses how to evaluate the short term cost of treatment with new hepatitis C drugs versus the long term cost of care.

This video was recorded courtesy of Armada Health Care at the 2015 Armada Specialty Pharmacy Summit in Las Vegas, Nevada.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Hepatitis C: Short Term Drug Costs Versus Long Term Care Costs

Newsletter